paraoxon has been researched along with Brain Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Daniels, D; Eisenkraft, A; Gilat, E; Kadar, T; Kapon, J; Krivoy, A; Last, D; Maier, S; Makarovski, I; Mardor, Y; Ramaty, E; Rosman, Y; Salomon, S; Schein, O; Shilderman, EB; Shneor, R; Shrot, S; Tamar, G | 1 |
| Berkutzki, T; Capacio, BA; Eisenkraft, A; Eisner, C; Finkelstein, A; Gonzales, M; Gregorowicz, D; Krivoy, A; Kunis, G; Last, D; Mardor, Y; McDonough, JH; McFarland, E; Ronen, A; Schwartz, M; Van Shura, K; Yoles, E | 1 |
2 other study(ies) available for paraoxon and Brain Diseases
| Article | Year |
|---|---|
Using MRI for the assessment of paraoxon-induced brain damage and efficacy of antidotal treatment.
Topics: Animals; Antidotes; Atropine; Brain; Brain Diseases; Cholinergic Antagonists; Cholinesterase Inhibitors; Cholinesterase Reactivators; GABA Modulators; Magnetic Resonance Imaging; Male; Midazolam; Obidoxime Chloride; Paraoxon; Rats; Rats, Sprague-Dawley; Scopolamine | 2012 |
Immunomodulation by poly-YE reduces organophosphate-induced brain damage.
Topics: Animals; Brain; Brain Diseases; Brain-Derived Neurotrophic Factor; CD4-Positive T-Lymphocytes; Cell Proliferation; Chemical Warfare Agents; Cholinesterase Inhibitors; Flow Cytometry; Image Processing, Computer-Assisted; Immunohistochemistry; Immunologic Factors; Magnetic Resonance Imaging; Male; Maze Learning; Motor Activity; Neuroprotective Agents; Organophosphorus Compounds; Paraoxon; Peptides; Rats; Rats, Sprague-Dawley; Soman; T-Lymphocytes | 2012 |